X
15Dec

Life Sciences Dealmaking Symposium: Powering through the Pandemic: Trends in Early-Stage Investment

The pursuit of progress during these unprecedented times has led to a surge in life sciences investment and funding for early stage companies. Investors are on the lookout for the next big innovation while also navigating new ways of sourcing and managing portfolio companies. Our panel of experienced early-stage investors discussed the top trends in this push for advancement, including sectors attracting the most dollars in today’s challenging business landscape, key issues that early stage...
By: McDermott Will & Emery
Source Url: https://www.jdsupra.com/legalnews/life-sciences-dealmaking-symposium-30857/

Related

Sistemi di accumulo e decreto semplificazioni

I) Il decreto semplificazioni (recentemente convertito in legge) ha introdotto novità non solo nel s...

Read More >

Rep And Warranty Insurance Has Growing Popularity In PE Deals

Private equity buyers have become a significant player in the healthcare M&A space and they continue...

Read More >

[Video] Daily Compliance News: September 3, 2019- the savage v. sauvage edition

In today’s edition of Daily Compliance News: 1. CFO’s say new lease accounting rules are tough. (...

Read More >

Investment Funds: Sun Capital Reversal Offers Important Takeaways Regarding Portfolio Company Pension Liabilities

The First Circuit reverses a lower court decision and finds two Sun Capital private equity funds are...

Read More >

Life Insurer Compelled to Produce Attorney-Client Communications

A federal district court in Ohio concluded that internal communications between a plan administrator...

Read More >

NLRB Serves Up An Epic Ruling For Employers

In its first significant decision applying the Supreme Court’s holding in Epic Systems v. NLRB, 584...

Read More >